MyFinsight
Home
Blog
About
Proceeds from exercise of
common stock warrants
$4,058K
Proceeds from issuance of
common stock under...
$170K
Net cash provided by
financing activities
$3,978K
(140.94%↑ Y/Y)
Canceled cashflow
$250K
Net increase
(decrease) in cash, cash...
-$34,400K
(23.85%↑ Y/Y)
Canceled cashflow
$3,978K
Stock-based compensation
expense
$5,027K
(57.54%↑ Y/Y)
Non-cash operating lease
expense
$860K
(11.11%↑ Y/Y)
Depreciation
$559K
(-0.18%↓ Y/Y)
Non-cash interest
expense
$127K
(-18.06%↓ Y/Y)
Principal payments on
finance lease...
$250K
(13.12%↑ Y/Y)
Net cash used in
operating activities
-$38,378K
(17.07%↑ Y/Y)
Canceled cashflow
$6,573K
Change in fair value of
warrant liabilities
-$24,571K
(-5051.15%↓ Y/Y)
Net loss
-$16,320K
(68.39%↑ Y/Y)
Accrued expenses and
other current...
-$1,888K
(-235.44%↓ Y/Y)
Operating lease
liabilities
-$770K
(-27.27%↓ Y/Y)
Accounts payable
-$568K
(-184.65%↓ Y/Y)
Prepaid expenses and
other current assets
$484K
(183.04%↑ Y/Y)
Other long-term
assets and liabilities
$210K
(400.00%↑ Y/Y)
Change in fair value of
notes payable,...
-$140K
(20.90%↑ Y/Y)
Back
Back
Cash Flow
FRACTYL HEALTH, INC. (GUTS)
FRACTYL HEALTH, INC. (GUTS)
source: myfinsight.com